Transgenomic Posts Slight Rise in Q2 Revenues, Modest Profit | GenomeWeb
NEW YORK (GenomeWeb News) — Transgenomic yesterday said first-quarter revenues inched up 1.5 percent as R&D spending increased 7 percent and the company turned last year’s loss to a modest profit.     
 
Total receipts for the three months ended June 31 rose to $6.3 million from $6.2 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.